# Centre Hospitalier Universitaire de Grenoble

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/centre-hospitalier-universitaire-de-grenoble/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 71.8 |
| Citations | 1,650,018 |
| City | Grenoble |
| Country | FR |
| Description | Centre Hospitalier Universitaire de Grenoble is a research organisation in Grenoble, FR. OpenAlex records 26,309 works and 1,650,018 citations for it. 6,216 researchers list it as their most recent affiliation. |
| Homepage | http://www.chu-grenoble.fr/ |
| OpenAlex ID | https://openalex.org/I2800555055 |
| Researchers | 6,216 |
| ROR ID | https://ror.org/041rhpw39 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q2945764 |
| Works | 26,309 |

## University papers

Showing 12 of 40.

- [Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC](https://scholariq.org/papers/atezolizumab-for-first-line-treatment-of-metastatic-nonsquamous-nsclc/)
- [Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer](https://scholariq.org/papers/crizotinib-versus-chemotherapy-in-advanced-i-alk-i-positive-lung-cancer/)
- [Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/durvalumab-plus-platinum-etoposide-versus-platinum-etoposide-in-first-line/)
- [First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study](https://scholariq.org/papers/first-line-ceritinib-versus-platinum-based-chemotherapy-in-advanced-alk/)
- [Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/bevacizumab-for-newly-diagnosed-pleural-mesothelioma-in-the-mesothelioma-avastin/)
- [Subthalamic Nucleus Stimulation in Severe Obsessive–Compulsive Disorder](https://scholariq.org/papers/subthalamic-nucleus-stimulation-in-severe-obsessive-compulsive-disorder/)
- [Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-bevacizumab-and-chemotherapy-in-non-small-cell-lung-cancer/)
- [Genetics and Outcome of Atypical Hemolytic Uremic Syndrome](https://scholariq.org/papers/genetics-and-outcome-of-atypical-hemolytic-uremic-syndrome/)
- [Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/durvalumab-with-or-without-tremelimumab-plus-platinum-etoposide-versus-platinum/)
- [Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer](https://scholariq.org/papers/intestinal-akkermansia-muciniphila-predicts-clinical-response-to-pd-1-blockade/)
- [Lung Cancer That Harbors an <i>HER2</i> Mutation: Epidemiologic Characteristics and Therapeutic Perspectives](https://scholariq.org/papers/lung-cancer-that-harbors-an-i-her2-i-mutation-epidemiologic-characteristics-and/)
- [Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers](https://scholariq.org/papers/ectopic-activation-of-germline-and-placental-genes-identifies-aggressive/)

## University researchers

- [Denis Moro‐Sibilot](https://scholariq.org/researchers/denis-moro-sibilot/)

## University top topics

Showing 8 of 25.

- [Obstructive Sleep Apnea Research](https://scholariq.org/topics/obstructive-sleep-apnea-research/)
- [Health, Medicine and Society](https://scholariq.org/topics/health-medicine-and-society/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Healthcare Systems and Practices](https://scholariq.org/topics/healthcare-systems-and-practices/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.